![]() |
市場調查報告書
商品編碼
1986459
消融設備市場報告:按設備技術、應用、最終用戶和地區分類(2026-2034 年)Ablation Devices Market Report by Device Technology, Application, End User, and Region 2026-2034 |
||||||
2025年全球消融設備市場規模達71億美元。展望未來,IMARC Group預測,到2034年,該市場規模將達到162億美元,2026年至2034年的複合年成長率為9.32%。市場成長的主要促進因素包括危及生命的疾病日益普遍、電生理技術在組織切除中的廣泛應用,以及配備機器人導航系統的新一代消融設備的研發。
消融裝置是一種醫療器械,用於各種醫療程序中,透過切除或破壞組織來治療或控制某些疾病。這些裝置的工作原理是利用熱能、冷能或射頻等能量照射目標組織,以達到切除或改變組織的目的。與傳統外科手術相比,消融手術通常更受歡迎,因為它們創傷小、疼痛輕、恢復期短,且併發症風險較低。
受多種關鍵因素驅動,該市場正在成長,其中包括癌症、心房顫動和慢性靜脈功能不全(CVI)等危及生命的疾病日益普遍。這些疾病發生率的上升凸顯了對有效消融手術日益成長的需求。此外,大眾對微創消融技術的認知度不斷提高,也促進了市場擴張。這些手術具有許多優勢,包括減輕疼痛、減少疤痕、降低不適感、縮短患者恢復時間。廣泛採用電生理手術去除異常組織以治療心律不整和心臟心律不整,也顯著促進了市場成長。此外,製造商正積極回應不斷變化的醫療需求,開發非熱消融、非充氣、非硬化性靜脈消融裝置,專門用於有效治療淺層靜脈逆流。
危及生命的疾病發生率正在上升。
癌症仍然是全球主要死因之一,近年來其發生率持續上升。消融手術作為一種微創手術治療方法,尤其在腫瘤學領域,正日益受到關注。這些手術用於摧毀包括肝臟、腎臟和肺部在內的各種器官中的癌症組織。此外,慢性靜脈功能不全(CVI)是一種腿部靜脈無法將血液充分回流至心臟的疾病,會導致疼痛、腫脹和皮膚改變。目前,經靜脈消融療法(透過封閉功能異常的靜脈)被廣泛用於治療CVI。 CVI的盛行率不斷上升,這通常與生活方式和老齡化有關,也推動了對專為靜脈治療而設計的消融設備的需求。
電生理學的普及
電生理學是循環系統的一個分支,主要研究心臟的電活動。由於其在診斷和治療包括心房顫動在內的各種心律不整方面的有效性,電生理學的應用正在迅速成長。電生理引導下的消融手術能夠精準地辨識並消除心臟內異常電訊號的來源。這種方法已成為許多心律不整的標準治療方法,能夠有效緩解症狀並提高患者的生活品質。此外,隨著醫療專業人員對電生理引導下消融術益處的認知不斷加深,其應用範圍也不斷擴大,對相關消融設備和器械的需求也日益成長。
下一代消融裝置與機器人導航系統的整合
消融設備領域的技術進步是推動其發展的主要動力。新一代消融設備整合了機器人導航系統,顯著提高了手術的準確性、精確性和療效。機器人輔助消融能夠達到更精準、更可控的組織消融,降低併發症風險,改善患者預後。這些機器人系統可提供治療區域的即時成像和映射,使醫護人員能夠更自信地操控複雜的解剖結構。因此,這些先進消融設備的應用日益廣泛,尤其是在那些致力於提供尖端治療方案的醫療機構中。由於預期患者安全性和手術成功率的提升,對這些設備的需求也不斷成長。
The global ablation devices market size reached USD 7.1 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 16.2 Billion by 2034, exhibiting a growth rate (CAGR) of 9.32% during 2026-2034. The increasing prevalence of life-threatening diseases, the widespread adoption of electrophysiology to remove abnormal tissues, and the development of next-generation ablation devices with robotic navigation systems represent some of the key factors driving the market.
Ablation devices are medical instruments or tools used in various medical procedures to remove or destroy tissue, typically with the goal of treating or managing certain medical conditions. These devices work by delivering energy, such as heat, cold, or radiofrequency, to the targeted tissue, causing its removal or alteration. Ablation procedures are minimally invasive and are often preferred over traditional surgical methods because they typically result in less pain, shorter recovery times, and reduced risk of complications.
The market is experiencing growth driven by several key factors, including the increasing prevalence of life-threatening diseases such as cancer, atrial fibrillation, and chronic venous insufficiency (CVI). This rise in disease incidence underscores the demand for effective ablation procedures. Furthermore, the growing awareness among the public about the availability of minimally invasive ablation techniques is propelling market expansion. These procedures offer numerous advantages, including reduced pain, minimal scarring, decreased discomfort, and quicker patient recovery times. Additionally, the widespread adoption of electrophysiology procedures to address irregular heart rhythms and cardiac arrhythmia by removing abnormal tissues is contributing significantly to market growth. Besides, manufacturers are also responding to evolving medical needs by creating non-thermal, non-tumescent, and non-sclerosant endovenous ablation devices tailored for the effective treatment of superficial vein reflux.
Increasing prevalence of life-threatening diseases
Cancer remains one of the leading causes of death worldwide, with a rising incidence in recent years. Ablation procedures, particularly in oncology, have gained prominence as minimally invasive alternatives to surgery. They are employed to destroy cancerous tissues in various organs, such as the liver, kidney, and lung. Moreover, CVI is a condition where veins in the legs fail to adequately return blood to the heart, leading to pain, swelling, and skin changes. Endovenous ablation procedures are now commonly used to treat CVI by closing off malfunctioning veins. The rising incidence of CVI, often associated with lifestyle factors and aging, has driven the demand for ablation devices designed for venous treatments.
Widespread adoption of electrophysiology
Electrophysiology is a branch of cardiology that deals with the electrical activity of the heart. It has witnessed a surge in adoption due to its effectiveness in diagnosing and treating various cardiac arrhythmias, including atrial fibrillation. Electrophysiology-guided ablation procedures involve precisely locating and eliminating the source of abnormal electrical signals in the heart. This approach has become the standard of care for many heart rhythm disorders, offering patients a chance for symptom relief and improved quality of life. Moreover, with healthcare professionals increasingly recognizing the benefits of electrophysiology-guided ablation, its adoption has become widespread, leading to a growing demand for related ablation devices and equipment.
Integration of next-generation ablation devices with robotic navigation systems
The advancement of technology in the field of ablation devices is a significant driving force. Next-generation ablation devices incorporate robotic navigation systems, which enhance precision, accuracy, and procedural outcomes. Robotic-assisted ablation allows for more controlled and targeted tissue ablation, reducing the risk of complications and improving patient outcomes. These robotic systems provide real-time imaging and mapping of the treatment area, enabling healthcare providers to navigate complex anatomical structures with greater confidence. As a result, the adoption of these advanced ablation devices is on the rise, particularly among healthcare facilities looking to offer state-of-the-art treatment options. The promise of improved patient safety and procedural success rates further fuels the demand for these devices.
Radiofrequency devices represent the most used device technology
RF ablation has demonstrated effectiveness across a wide range of medical applications. It is used to treat conditions such as cardiac arrhythmias (e.g., atrial fibrillation), liver tumors, kidney tumors, and chronic pain management. This versatility makes RF technology a go-to choice for physicians dealing with various medical specialties. Moreover, RF ablation has a long history of safe and successful use in medical procedures. The technology has been refined over the years, and clinicians have extensive experience with its application. This track record of safety and efficacy instills confidence in both healthcare providers and patients.
Cancer treatment holds the largest market share
Cancer is a widespread and prevalent disease that affects millions of people globally. It can occur in various organs and tissues, leading to a high demand for effective treatment options. As the incidence of cancer continues to rise due to factors like aging populations and lifestyle changes, the need for cancer treatment methods, including ablation, remains significant. Moreover, ablation techniques have proven to be versatile in the field of oncology. These procedures can be used to treat both primary tumors and metastatic lesions, making them applicable across different stages and types of cancer. Ablation can be employed in various organs, such as the liver, kidney, lung, and bone, providing clinicians with a wide range of treatment options.
Hospitals accounts for majority of market share
Ablation procedures often require specialized equipment and trained medical professionals. Hospitals are well-equipped to handle complex medical interventions and have the necessary infrastructure, including operating rooms, imaging technology, and support staff, to perform these procedures safely and effectively. This makes hospitals the natural choice for patients seeking ablation treatments. Moreover, hospitals house a wide range of medical specialties, including cardiology, oncology, gastroenterology, urology, and more. Ablation devices are used across multiple medical disciplines to treat various conditions. Hospitals can offer a comprehensive suite of ablation services, making them a one-stop destination for patients with diverse medical needs.
North America exhibits a clear dominance in the market
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America, particularly the United States and Canada, boasts a highly developed and advanced healthcare infrastructure. The region is home to world-renowned medical institutions, hospitals, and research centers. This advanced infrastructure provides a solid foundation for the adoption of cutting-edge medical technologies, including ablation devices. Moreover, the region has one of the highest healthcare expenditure rates in the world. This substantial investment in healthcare, both by governments and private entities, enables the procurement of state-of-the-art medical equipment, including ablation devices. It also supports research and development efforts in the healthcare sector, leading to innovation and product advancements.
The competitive landscape of the market is characterized by the presence of multiple players that include established brands, emerging startups, and specialty manufacturers. Presently, leading companies are allocating significant resources to research and development efforts to develop innovative and technologically advanced ablation devices. This includes the development of next-generation ablation systems with enhanced precision, safety features, and user-friendly interfaces. They are also expanding their product portfolios to offer a comprehensive range of ablation devices catering to various medical specialties and applications. This includes devices designed for cardiac ablation, oncology, pain management, gynecology, and more. Moreover, companies are expanding their reach into new geographical markets. This expansion involves obtaining regulatory approvals and certifications in different regions, establishing distribution networks, and adapting their products to meet specific regional requirements.
The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include: